Nibourel O, Guihard S, Roumier C, Pottier N, Terre C, Paquet A great, Peyrouze P, Geffroy S, Quentin S, Alberdi An excellent, Abdelali RB, Renneville A beneficial, Demay C, Celli-Lebras K, Barbry P, Quesnel B, Castaigne S, Dombret H, Soulier J, Preudhomme C, Cheok MH. Copy-count analysis recognized brand new prognostic ;31(3):555-564.
Mohamed In the morning, Balsat Yards, Koering C, Maucort-Boulch D, Boissel N, Payen-Gay L, Cheok Meters, Mortada H, Auboeuf D, Pinatel C, El-Hamri Yards, Tigaud I, Hayette S, Dumontet C, Cros Age, Flandrin-Gresta P, Nibourel O, Preudhomme C, Thomas X, Nicolini FE, Solly F, Guyotat D, Campos L, Michallet Yards, Ceraulo An effective, Mortreux F, Wattel E. Leuk Res. 2017;-28.
Mishima Y, Paiva B, Shi J, Playground J, Manier S, Takagi S, Massoud Meters, Perilla-Glen A, Aljawai Y, Huynh D, Roccaro Was, Sacco A beneficial, Capelletti Yards, Detappe A, Alignani D, Anderson KC, Munshi NC, Prosper F, Lohr JG, Ha Grams, Freeman SS, Van Allen EM, Adalsteinsson Va, Michor F, San Miguel JF, Ghobrial Im. 2017;19(1):218-224.
Minnema MC, Kimby Elizabeth, DSa S, Fornecker LM, Poulain S, Snijders TJ, Kastritis Elizabeth, Kremer S, Fitsiori A good, Simon L, Davi F, Lunn Yards, Castillo JJ, Patterson CJ, Le Garff-Tavernier M, Costopoulos Meters, Leblond V, Kersten MJ, Dimopoulos MA, Treon SP. Guideline to the medical diagnosis, procedures and you may effect conditions having Google-Neel disorder. Haematologica. 2017;102(1):43-51.
Micol JB, Pastore Good, Inoue D, Duployez Letter, Kim Age, Lee Sc, Durham BH, Chung Year, Cho H, Zhang XJ, Yoshimi A good, Krivtsov A, Koche R, Solary Elizabeth, Sinha A beneficial, Preudhomme C, Abdel-Wahab O. ASXL2 is important to have haematopoiesis and you can will act as a great haploinsufficient tumour suppressor inside the leukemia. Nat Commun. 2017;8:15429.
Cellphone Associate
Meunier Yards, Ancelet S, Lefebvre C, Arnaud J, Garrel C, Pezet Meters, Wang Y, Faure P, Szymanski G, Duployez N, Preudhomme C, Biard D, Polack B, Cahn JY, Moulis JM, Park S. Activated outdoors varieties levels manage NF-kappaB activation from the reasonable serving deferasirox within the erythroid progenitors out-of lowest exposure myelodysplastic syndromes. Oncotarget. 2017;8(62):105510-105524.
Manier S, Salem KZ, Park J, Landau Weil, Getz Grams, Ghobrial I’m. Genomic complexity of several myeloma and its clinical effects. Nat Rev Clin Oncol. 2017;14(2):100-113.
Manier S, Vitality JT, Sacco A beneficial, Glavey SV, Huynh D, Reagan MR, Salem KZ, Moschetta Yards, Shi J, Mishima Y, Roche-Lestienne C, Leleu X, Roccaro Was, Daley GQ, Ghobrial I’m. The brand new LIN28B/let-eight axis was a manuscript therapeutic path inside multiple myeloma. Leukemia. 2017;31(4):853-860.
Manier S, Liu CJ, Avet-Loiseau H, Playground J, Shi J, Campigotto F, Salem KZ, Huynh D, Glavey SV, Rivotto B, Sacco Good, Roccaro Are, Bouyssou J, Minvielle S, Moreau P, Facon T, Leleu X, Weller Elizabeth, Trippa L, Ghobrial I will be. Prognostic character away from dispersing exosomal miRNAs within the several myeloma. Blood. 2017;129(17):2429-2436.
TET2 exon dos missing was another beneficial prognostic grounds to own cytogenetically regular serious myelogenous leukemia (AML): TET2 exon 2 skipping inside the AML
Manier S, Huynh D, Shen YJ, Zhou J, Yusufzai T, Salem KZ, Ebright RY, Shi J, Park J, Glavey SV, Devine WG, Liu CJ, Leleu X, Quesnel B, Roche-Lestienne C, Snyder JK, Brown Ce, Gray Letter, Bradner J, Whitesell L, Porco JA, Jr., Ghobrial I’m. Inhibiting this new oncogenic translation program is an efficient healing means in the multiple myeloma. Sci http://www.datingranking.net/pl/brazilcupid-recenzja/ Transl Med. 2017;9(389).
Magnez Roentgen, Thiroux B, Taront S, Segaoula Z, Quesnel B, Thuru X. PD-1/PD-L1 joining education using microscale thermophoresis. Sci Rep. 2017;7(1):17623.
Lacombe F, Campos L, Allou K, Arnoulet C, Delabarthe A, Dumezy F, Feuillard J, Genevieve F, Guerin Elizabeth, Son J, Jouault H, Lepelley P, Maynadie Yards, Solly F, Ballon OW, Preudhomme C, Baruchel An excellent, Dombret H, Ifrah N, Bene MC. Prognostic value of multicenter circulate cytometry matched up research of restricted residual situation inside the severe myeloblastic leukemia. Hematol Oncol. 2017.